Surgery Partners, Inc. (NASDAQ:SGRY) Given Consensus Rating of “Moderate Buy” by Brokerages

Surgery Partners, Inc. (NASDAQ:SGRY) has received an average recommendation of “Moderate Buy” from the twelve research firms that are currently covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, two have issued a hold recommendation, eight have given a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year target price among analysts that have issued ratings on the stock in the last year is $22.1818.

Several research firms have weighed in on SGRY. Jefferies Financial Group reaffirmed a “buy” rating and issued a $17.00 target price on shares of Surgery Partners in a research report on Wednesday, May 6th. TD Cowen dropped their target price on Surgery Partners from $28.00 to $20.00 and set a “buy” rating for the company in a research report on Thursday, March 5th. UBS Group reaffirmed a “buy” rating on shares of Surgery Partners in a research report on Wednesday, March 11th. Barclays decreased their target price on Surgery Partners from $18.00 to $14.00 and set an “equal weight” rating for the company in a research note on Tuesday, March 3rd. Finally, Zacks Research upgraded Surgery Partners from a “hold” rating to a “strong-buy” rating in a research note on Thursday, June 4th.

Institutional Investors Weigh In On Surgery Partners

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. State of Wisconsin Investment Board increased its holdings in shares of Surgery Partners by 0.4% in the fourth quarter. State of Wisconsin Investment Board now owns 151,504 shares of the company’s stock valued at $2,341,000 after purchasing an additional 668 shares during the period. ProShare Advisors LLC grew its holdings in Surgery Partners by 6.9% during the fourth quarter. ProShare Advisors LLC now owns 14,135 shares of the company’s stock worth $218,000 after acquiring an additional 909 shares during the period. Jones Financial Companies Lllp grew its holdings in Surgery Partners by 313.1% during the third quarter. Jones Financial Companies Lllp now owns 1,227 shares of the company’s stock worth $27,000 after acquiring an additional 930 shares during the period. California State Teachers Retirement System grew its holdings in Surgery Partners by 1.6% during the second quarter. California State Teachers Retirement System now owns 65,091 shares of the company’s stock worth $1,447,000 after acquiring an additional 1,021 shares during the period. Finally, Sanctuary Advisors LLC grew its holdings in Surgery Partners by 4.5% during the fourth quarter. Sanctuary Advisors LLC now owns 28,488 shares of the company’s stock worth $440,000 after acquiring an additional 1,218 shares during the period.

Surgery Partners Price Performance

Shares of NASDAQ:SGRY opened at $14.55 on Wednesday. The business has a 50-day moving average price of $13.98 and a 200 day moving average price of $14.44. The company has a current ratio of 1.86, a quick ratio of 1.69 and a debt-to-equity ratio of 1.17. The company has a market capitalization of $1.90 billion, a price-to-earnings ratio of -24.25, a PEG ratio of 4.35 and a beta of 1.96. Surgery Partners has a 12-month low of $11.41 and a 12-month high of $24.10.

Surgery Partners (NASDAQ:SGRY) last issued its quarterly earnings data on Tuesday, May 5th. The company reported ($0.03) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.15) by $0.12. The firm had revenue of $810.90 million during the quarter, compared to the consensus estimate of $797.69 million. Surgery Partners had a positive return on equity of 1.04% and a negative net margin of 2.28%.The company’s quarterly revenue was up 4.5% on a year-over-year basis. During the same period last year, the company earned $0.04 EPS. Sell-side analysts expect that Surgery Partners will post 0.25 EPS for the current year.

Surgery Partners announced that its Board of Directors has authorized a share buyback plan on Thursday, February 26th that permits the company to repurchase $200.00 million in shares. This repurchase authorization permits the company to buy up to 9.7% of its stock through open market purchases. Stock repurchase plans are usually an indication that the company’s management believes its shares are undervalued.

About Surgery Partners

Surgery Partners, Inc operates as a healthcare services provider specializing in the management and ownership of ambulatory surgery centers, surgical hospitals and multispecialty rehabilitation hospitals across the United States. Through its network of facilities, the company coordinates and delivers a broad range of outpatient surgical procedures in specialties such as orthopedics, ophthalmology, otolaryngology, gastroenterology, pain management and general surgery. Its integrated platform offers ancillary services including on-site imaging, laboratory testing, infusion therapy and physical, occupational and speech rehabilitation.

Since its establishment in 2010 and subsequent public listing in 2015, Surgery Partners has focused on strategic partnerships with physicians and health systems to expand access to cost-effective outpatient care.